Limba
|
Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1with IC50of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Rigosertib inhibits PI3K/Aktpathway and activates oxidative stress signals. Rigosertib induces apoptosisin various cancer cells. Phase 3.
Price | 21.766,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1with IC50of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Rigosertib inhibits PI3K/Aktpathway and activates oxidative stress signals. Rigosertib induces apoptosisin various cancer cells. Phase 3. |